I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 65 filers reported holding I MAB in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $954,730 | -84.5% | 723,280 | -64.9% | 0.00% | – |
| Q2 2023 | $6,155,336 | -8.6% | 2,058,641 | +5.8% | 0.00% | – |
| Q1 2023 | $6,735,411 | -19.0% | 1,946,651 | -2.2% | 0.00% | – |
| Q4 2022 | $8,320,098 | -8.7% | 1,990,454 | -12.4% | 0.00% | – |
| Q3 2022 | $9,110,000 | -69.4% | 2,271,671 | -13.9% | 0.00% | -100.0% |
| Q2 2022 | $29,806,000 | -46.1% | 2,637,832 | -22.5% | 0.00% | 0.0% |
| Q1 2022 | $55,270,000 | -52.7% | 3,403,271 | +38.1% | 0.00% | -66.7% |
| Q4 2021 | $116,803,000 | -14.9% | 2,464,740 | +30.2% | 0.00% | -25.0% |
| Q3 2021 | $137,193,000 | -8.8% | 1,892,598 | +5.6% | 0.00% | 0.0% |
| Q2 2021 | $150,428,000 | +1841.0% | 1,791,872 | +1020.7% | 0.00% | – |
| Q1 2021 | $7,750,000 | +11.8% | 159,884 | +8.8% | 0.00% | – |
| Q4 2020 | $6,929,000 | +6970.4% | 146,955 | +6951.6% | 0.00% | – |
| Q3 2020 | $98,000 | +1300.0% | 2,084 | +309.4% | 0.00% | – |
| Q1 2020 | $7,000 | – | 509 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDBI Pte Ltd | 222,136 | $768,591 | 0.86% |
| HHLR ADVISORS, LTD. | 6,954,442 | $24,062,369 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 310,499 | $1,074,327 | 0.30% |
| Maso Capital Partners Ltd | 100,000 | $346 | 0.23% |
| Artal Group S.A. | 850,000 | $2,941 | 0.18% |
| Virtus ETF Advisers LLC | 26,347 | $91,161 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 96,555 | $334 | 0.03% |
| CAXTON ASSOCIATES LP | 53,793 | $186,124 | 0.03% |
| Diametric Capital, LP | 13,924 | $48,177 | 0.02% |
| Tekla Capital Management LLC | 162,580 | $562,527 | 0.02% |